Aarti Drugs

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue687.77664.97743.28661.71642.23
Expenses634.58615.29670.00598.18585.96
EBITDA74.3271.6694.4184.6777.13
EBIT61.6659.0481.9172.0764.52
Profit Before Tax53.1949.6873.2863.5356.27
Net Profit38.7436.6756.1847.9739.60
Financial Ratios
Operating Profit Margin10.81%10.79%12.72%12.81%12.02%
Net Profit Margin5.63%5.52%7.56%7.24%6.17%
Earning Per Share (Diluted)4.183.966.075.184.29
Dividends Per Share0.001.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ